Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 147 Breast Neoplasms 108 Lung Neoplasms 92 Carcinoma, Non-Small-Cell Lung 77 Neoplasm Metastasis 68 Glioblastoma 68 Brain Neoplasms 64 Glioma 59 Pancreatic Neoplasms 45 Carcinoma, Renal Cell 43 Multiple Myeloma 41 Squamous Cell Carcinoma of Head and Neck 39 Colorectal Neoplasms 38 Lymphoma, Large B-Cell, Diffuse 37 Neoplasms 34 Melanoma 32 Lymphoma 32 Carcinoma, Hepatocellular 32 Urinary Bladder Neoplasms 31 Ovarian Neoplasms 29 Astrocytoma 28 Sarcoma 25 Oropharyngeal Neoplasms 24 Lymphoma, Follicular 23 Central Nervous System Neoplasms 23 Rectal Neoplasms 22 Uterine Cervical Neoplasms 21 Triple Negative Breast Neoplasms 21 Mouth Neoplasms 21 Lymphoma, Non-Hodgkin 21

Interventions

pembrolizumab 1 gadobutrol 1 Standard of Care 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Limonene 1 Erlotinib Hydrochloride 1 Docetaxel 1 Citric Acid 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Parotid Neoplasms × Magnetic Resonance Spectroscopy × Clear all

NCT03950323 2020-04-14

R-PO19053

CHU de Reims

Phase NA Unknown

Facial Paralysis, Parotid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡